{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:02:42Z","timestamp":1749268962860,"version":"3.41.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jhepr.2024.101324","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:17:39Z","timestamp":1735690659000},"page":"101324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diversity and inclusion in chronic hepatitis B randomised controlled trials: A systematic meta-epidemiological review"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9775-9057","authenticated-orcid":false,"given":"Xintong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7509-0512","authenticated-orcid":false,"given":"Angela C.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva R.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-3292","authenticated-orcid":false,"given":"Karen M.J.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2024.101324_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Sheena","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101324_bib2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S2468-1253(23)00156-5","article-title":"A\u00a0global investment case for hepatitis B\u00a0elimination: a modelling study","volume":"8","author":"Seaman","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101324_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jclinepi.2013.05.009","article-title":"Heterogeneity and clinical reality","volume":"66","author":"Knottnerus","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"year":"2022","key":"10.1016\/j.jhepr.2024.101324_bib4"},{"key":"10.1016\/j.jhepr.2024.101324_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2023.107092","article-title":"Diversity, equity, and inclusion in clinical trials: a practical guide from the perspective of a trial sponsor","volume":"126","author":"Versavel","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jhepr.2024.101324_bib6","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2024.101324_bib7","unstructured":"World Health Organization. WHO statement on public disclosure of clinical trial results. https:\/\/cdn.who.int\/media\/docs\/default-source\/medicines\/regulatory-updates\/who_statement_results_reporting_clinical_trials.pdf?sfvrsn=805357d7_5#:\u223c:text=Negative20and20inconclusive20as20well,trials20conducted20in20the20past. [Accessed 18 June 2024]."},{"key":"10.1016\/j.jhepr.2024.101324_bib8","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2022. Available from https:\/\/vizhub.healthdata.org\/gbd-results\/. [Accessed 20 June 2024]."},{"key":"10.1016\/j.jhepr.2024.101324_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","article-title":"Hepatitis B virus infection in children and adolescents","volume":"4","author":"Indolfi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101324_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.12688\/wellcomeopenres.17601.3","article-title":"Sexual dimorphism in chronic hepatitis B virus (HBV) infection: evidence to inform elimination efforts","volume":"7","author":"Matthews","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jhepr.2024.101324_bib11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/jgh.12934","article-title":"Gender disparity in chronic hepatitis B:\u00a0mechanisms of sex hormones","volume":"30","author":"Wang","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101324_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/genes9100495","article-title":"The global hepatitis B virus genotype distribution approximated from available genotyping data","volume":"9","author":"Velkov","year":"2018","journal-title":"Genes (Basel)"},{"year":"2016","series-title":"No. 7528 the World Bank's classification of countries by income","key":"10.1016\/j.jhepr.2024.101324_bib13"},{"key":"10.1016\/j.jhepr.2024.101324_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(23)00315-1","article-title":"Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection","volume":"9","author":"Delphin","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101324_bib15","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2024.101324_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/ebmed-2017-110713","article-title":"Guidelines for reporting meta-epidemiological methodology research","volume":"22","author":"Murad","year":"2017","journal-title":"Evid Based Med"},{"key":"10.1016\/j.jhepr.2024.101324_bib17","unstructured":"Veritas Health Innovation. Covidence systematic review software. www.covidence.org."},{"key":"10.1016\/j.jhepr.2024.101324_bib20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.2021.2104","article-title":"The reporting of race and ethnicity in medical and science journals: comments invited","volume":"325","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2024.101324_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"year":"2020","series-title":"RStudio: integrated development environment for R. Boston, MA","key":"10.1016\/j.jhepr.2024.101324_bib22"},{"year":"2016","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","key":"10.1016\/j.jhepr.2024.101324_bib23"},{"key":"10.1016\/j.jhepr.2024.101324_bib24","first-page":"35","article-title":"rworldmap: a new R package for mapping global data","volume":"3","author":"South","year":"2011","journal-title":"R\u00a0J"},{"key":"10.1016\/j.jhepr.2024.101324_bib25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5694\/mja2.51430","article-title":"Australian consensus recommendations for the management of hepatitis B","volume":"216","author":"Lubel","year":"2022","journal-title":"Med J Aust"},{"key":"10.1016\/j.jhepr.2024.101324_bib26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/cid\/ciad506","article-title":"Chronic hepatitis B finite treatment: similar and different concerns with new drug classes","volume":"78","author":"Peters","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2024.101324_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jhep.2009.12.014","article-title":"Is response to antiviral treatment influenced by hepatitis B virus genotype?","volume":"52","author":"Raimondi","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2024.101324_bib28","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/S0140-6736(24)01081-X","article-title":"The Lancet Group\u2019s new guidance to authors on reporting race and ethnicity","volume":"403","author":"Chew","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2024.101324_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/bioe.12757","article-title":"Navigating conflicts of justice in the use of race and ethnicity in precision medicine","volume":"34","author":"Schaefer","year":"2020","journal-title":"Bioethics"},{"key":"10.1016\/j.jhepr.2024.101324_bib31","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4254\/wjh.v13.i12.1875","article-title":"Genotype E: the neglected genotype of hepatitis B virus","volume":"13","author":"Ingasia","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2024.101324_bib32","article-title":"Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries","volume":"5","author":"Mitchell","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101324_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12992-020-00609-9","article-title":"HIV\/AIDS research in Africa and the Middle East: participation and equity in North-South collaborations and relationships","volume":"16","author":"Gonz\u00e1lez-Alcaide","year":"2020","journal-title":"Glob Health"},{"key":"10.1016\/j.jhepr.2024.101324_bib34","unstructured":"World Health Organization. Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination. https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA75\/A75_R8-en.pdf 2022. [Accessed 1 September 2023]."},{"first-page":"359","year":"2006","series-title":"General comment No. 14 (2000) on the right to the highest attainable standard of health","key":"10.1016\/j.jhepr.2024.101324_bib35"},{"key":"10.1016\/j.jhepr.2024.101324_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-002921","article-title":"Research for Health Justice: an ethical framework linking global health research to health equity","volume":"6","author":"Pratt","year":"2021","journal-title":"BMJ Glob Health"},{"year":"2024","series-title":"Guidance for best practices for clinical trials","key":"10.1016\/j.jhepr.2024.101324_bib37"},{"key":"10.1016\/j.jhepr.2024.101324_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"year":"2023","series-title":"E21: inclusion of pregnant and breast-feeding individuals in clinical trials. Geneva, ICH","key":"10.1016\/j.jhepr.2024.101324_bib39"},{"key":"10.1016\/j.jhepr.2024.101324_bib40","article-title":"Clinical trial exclusion criteria affect trial inclusivity by race and sex","volume":"13","author":"Stanton","year":"2024","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jhepr.2024.101324_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhep.2024.02.033","article-title":"Sex and ethnic disparities in\u00a0hepatitis B evaluation and treatment across the world","volume":"81","author":"Kudaravalli","year":"2024","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101324_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41073-016-0007-6","article-title":"Sex and gender equity in research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"Heidari","year":"2016","journal-title":"Res Integr Peer Rev"},{"key":"10.1016\/j.jhepr.2024.101324_bib43","unstructured":"National Institutes of Health. Revision: NIH policy and guidelines on the inclusion of individuals across the lifespan as participants in research involving human subjects. https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-OD-18-116.html; 2017. [Accessed 1 September 2023]."},{"key":"10.1016\/j.jhepr.2024.101324_bib44","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101324_bib45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J\u00a0Hepatol"},{"year":"2024","series-title":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection","key":"10.1016\/j.jhepr.2024.101324_bib46"},{"key":"10.1016\/j.jhepr.2024.101324_bib47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12072-023-10597-8","article-title":"Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?","volume":"18","author":"Wang","year":"2024","journal-title":"Hepatol Int"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924003288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924003288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:56:20Z","timestamp":1749196580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924003288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2589555924003288"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101324","relation":{},"ISSN":["2589-5559"],"issn-type":[{"type":"print","value":"2589-5559"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diversity and inclusion in chronic hepatitis B randomised controlled trials: A systematic meta-epidemiological review","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101324"}}